Comparison of levofloxacin and sparfloxacin concentration in prostatic tissue

Japanese Journal of Chemotherapy

Volumn 46, Issue 5, 1998, Pages 188-194

  Ueda, Haruhiko ^a   Suzuki, Toshiaki ^b   Kanehara, Hironori ^b   Itoh, Susumu ^b   Yamamoto, Kazuhisa ^b   Takasaki, Noboru ^b   Katsuoka, Yoji ^b  

^a Saiseikai Ibaraki Hospital   (Japan)

^b OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

Levofloxacin; Sparfloxacin

Indexed keywords

LEVOFLOXACIN; SPARFLOXACIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG PENETRATION; DRUG TISSUE LEVEL; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PROSTATE HYPERTROPHY; PROSTATITIS; TRANSURETHRAL RESECTION;

EID: 0031812225     PISSN: 13407007     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Nakashima M, Uematsu T, Kanamaru M, et al.: Phase I study of Levofloxacin, (s) -(-) - Ofloxacin. Jpn J Clin Pharmacol Ther 23: 515-520, 1992
2. Chemothepapy 39: 138-144, 199
3. Chemotherapy 33: 325-329, 1985
4. Stamy T A, Meares E M Jr, Winningham D G: Chronic bacterial prostatitis and the diffusion of drugs into prostatic fluid. J Urol 103: 187-194, 1970
5. Chemotherapy 33: 671-683, 1985
6. Chemotherapy 34: 530-535, 1986